1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2.Strategic Recommendations
3.Gene and Cell Therapy Market: Product Outlook
4. Global Gene and Cell Therapy Market: Sizing and Forecast
4.1 Global Gene and Cell Therapy Market Size, By Value, Year 2016-2026
5. Global Gene and Cell Therapy Market Segmentation - By Vector, By Application
5.1 Competitive Scenario of Global Gene and Cell Therapy Market: By Vector
5.1.1 Lentivirus - Market Size and Forecast (2016-2026)
5.1.2 AAV - Market Size and Forecast (2016-2026)
5.1.3 Retrovirus & Gammaretrovirus - Market Size and Forecast (2016-2026)
5.1.4 Others - Market Size and Forecast (2016-2026)
5.2 Competitive Scenario of Global Gene and Cell Therapy Market: By Application
5.2.1 Oncology - Market Size and Forecast (2016-2026)
5.2.2 Neurological Disorders - Market Size and Forecast (2016-2026)
5.2.3 cardiovascular disorders - Market Size and Forecast (2016-2026)
5.2.4 Others - Market Size and Forecast (2016-2026)
6. Global Gene and Cell Therapy Market: Regional Analysis
6.1 Competitive Scenario of Global Gene and Cell Therapy Market : By Region
7. North America Gene and Cell Therapy Market: An Analysis (2016-2026)
7.1 North America Gene and Cell Therapy Market : Size and Forecast (2016-2026), By Value
Table 19: North America Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Table 20: North America Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Table 21: North America Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 22: North America Prevalence of Total Cancer, 2015-2019 (In Millions)
7.2 North America Gene and Cell Therapy Market - Prominent Companies
7.3 Market Segmentation By Vector (Lentivirus, AAV, Retrovirus & Gammaretrovirus and Others)
Table 23: North America Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
7.4 Market Segmentation By Application (Oncology, Neurological Disorders, cardiovascular disorders and Others)
Table 24: North America Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
7.5 North America Gene and Cell Therapy Market: Country Analysis
7.6 Market Opportunity Chart of North America Gene and Cell Therapy Market - By Country, By Value, 2026
Table 25: Market Opportunity Chart of North America Gene and Cell Therapy Market- By Country, By Value (Year-2026)
7.7 Competitive Scenario of North America Gene and Cell Therapy Market: By Country
Table 26: North America Gene and Cell Therapy Market- By Country Market Share, 2020 & 2026
7.8 United States Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
Table 27: United States Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Table 28: United State Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Table 29: United State Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 30: United State Prevalence of Total Cancer, 2015-2019 (In Millions)
7.9 United States Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
Table 31: United State Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Table 32: United State Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
7.10 Canada Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
Table 33: Canada Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Table 34: Canada Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Table 35: Canada Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 36: Canada Prevalence of Total Cancer, 2015-2019 (In Millions)
7.11 Canada Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
Table 37: Canada Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Table 38: Canada Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
8. Europe Gene and Cell Therapy Market: An Analysis (2016-2026)
8.1 Europe Gene and Cell Therapy Market : Size and Forecast (2016-2026), By Value
Table 39: Europe Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Table 40: Europe Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Table 41: Europe Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 42: Europe Prevalence of Total Cancer, 2015-2019 (In Millions)
8.2 Europe Gene and Cell Therapy Market - Prominent Companies
8.3 Market Segmentation By Vector (Lentivirus, AAV, Retrovirus & Gammaretrovirus and Others)
Table 43: Europe Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
8.4 Market Segmentation By Application (Oncology, Neurological Disorders, cardiovascular disorders and Others)
Table 44: Europe Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
8.5 Europe Gene and Cell Therapy Market: Country Analysis
8.6 Market Opportunity Chart of Europe Gene and Cell Therapy Market - By Country, By Value, 2026
Table 45: Market Opportunity Chart of Europe Gene and Cell Therapy Market- By Country, By Value (Year-2026)
8.7 Competitive Scenario of Europe Gene and Cell Therapy Market: By Country
Table 46: Europe Gene and Cell Therapy Market- By Country Market Share, 2020 & 2026
8.8 Germany Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
Table 47: Germany Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Table 48: Germany Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Table 49: Germany Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 50: Germany Prevalence of Total Cancer, 2015-2019 (In Millions)
8.9 Germany Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
Table 51: Germany Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Table 52: Germany Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
8.10 United Kingdom Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
Table 53: United Kingdom Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Table 54: United Kingdom Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Table 55: United Kingdom Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 56: United Kingdom Prevalence of Total Cancer, 2015-2019 (In Millions)
8.11 United Kingdom Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
Table 57: United Kingdom Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Table 58: United Kingdom Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
8.12 France Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
Table 59: France Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Table 60: France Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Table 61: France Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 62: France Prevalence of Total Cancer, 2015-2019 (In Millions)
8.13 France Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
Table 63: France Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Table 64: France Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
8.14 Italy Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
Table 65: Italy Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Billion)
Table 66: Italy Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Table 67: Italy Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 68: Italy Prevalence of Total Cancer, 2015-2019 (In Millions)
8.15 Italy Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
Table 69: Italy Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Table 70: Italy Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
9. Asia Pacific Gene and Cell Therapy Market: An Analysis (2016-2026)
9.1 Asia Pacific Gene and Cell Therapy Market : Size and Forecast (2016-2026), By Value
Table 71: Asia Pacific Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Table 72: Asia Pacific Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Table 73: Asia Pacific Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 74: Asia Pacific Prevalence of Total Cancer, 2015-2019 (In Millions)
9.2 Asia Pacific Gene and Cell Therapy Market - Prominent Companies
9.3 Market Segmentation By Vector (Lentivirus, AAV, Retrovirus & Gammaretrovirus and Others)
Table 75: Asia Pacific Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
9.4 Market Segmentation By Application (Oncology, Neurological Disorders, cardiovascular disorders and Others)
Table 76: Asia Pacific Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
9.5 Asia Pacific Gene and Cell Therapy Market: Country Analysis
9.6 Market Opportunity Chart of Asia Pacific Gene and Cell Therapy Market - By Country, By Value, 2026
Table 77: Market Opportunity Chart of APAC Gene and Cell Therapy Market- By Country, By Value (Year-2026)
9.7 Competitive Scenario of Asia Pacific Gene and Cell Therapy Market: By Country
Table 78: APAC Gene and Cell Therapy Market- By Country Market Share, 2020 & 2026
9.8 China Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
Table 79: China Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Table 80: China Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Table 81: China Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 82: China Prevalence of Total Cancer, 2015-2019 (In Millions)
9.9 China Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
Table 83: China Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Table 84: China Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
9.10 Japan Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
Table 85: Japan Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Table 86: Japan Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Table 87: Japan Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 88: Japan Prevalence of Total Cancer, 2015-2019 (In Millions)
9.11 Japan Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
Table 89: Japan Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Table 90: Japan Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
9.12 India Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
Table 91: India Pharmacy Retail Market Size, By Value, 2016-2026 (USD Billion)
Table 92: India Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Table 93: India Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 94: India Prevalence of Total Cancer, 2015-2019 (In Millions)
9.13 India Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
Table 95: India Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Table 96: India Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
9.14 South Korea Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
Table 97: South Korea Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Table 98: South Korea Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Table 99: South Korea Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 100: South Korea Prevalence of Total Cancer, 2015-2019 (In Millions)
9.15 South Korea Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
Table 101: South Korea Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Table 102: South Korea Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
10.Global Gene and Cell Therapy Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends
11.Market Attractiveness
11.2 Market Attractiveness Chart of Global Gene and Cell Therapy Market - By Vector, 2026
Table 103: Market Attractiveness Chart of Global Gene and Cell Therapy Market- By Vector (Year-2026)
11.3 Market Attractiveness Chart of Global Gene and Cell Therapy Market - Application, 2026
Table 104: Market Attractiveness Chart of Global Gene and Cell Therapy Market- By Application (Year-2026)
11.4 Market Attractiveness Chart of Global Gene and Cell Therapy Market - By Region, 2026
Table 105: Market Attractiveness Chart of Global Gene and Cell Therapy Market- By Region (Year-2026)
12.Competitive Landscape
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 Product Pipeline of Leading Gene Therapy Companies
12.3 Market Share Analysis
Table 106: Global Gene and Cell Therapy company market share (%), 2020
13.Company Analysis
13.1 F. Hoffman-La Roche Ltd.
Table 107: F. Hoffman-La Roche Ltd. Sales Revenues, 2016-2020 (USD Million)
Table 108: F. Hoffman-La Roche Ltd. Net Income, 2016-2020 (USD Million)
Table 109: F. Hoffman-La Roche Ltd. sales Revenues, By Business Segment (%), FY2020
Table 110: F. Hoffman-La Roche Ltd. sales Revenue, By Geographical Segment (%), FY2020
13.2 Novartis
Table 111: Novartis Annual Sales Revenue (USD Million), 2016-2020
Table 112: Novartis Annual Net Income/Loss (USD Million), 2016-2020
Table 113: Novartis Sales Revenue Split, By Business Segment (USD Million), FY2020
Table 114: Novartis Sales Revenue Split, By Geography Segment (%), FY2020
13.3 Sanofi
Table 115: Sanofi Sales Revenues, 2016-2020 (USD Million)
Table 116: Sanofi Gross Profit, 2016-2020 (USD Million)
Table 117: Sanofi Sales Revenue Split, By Business Segment (%), FY2020
Table 118: Sanofi Sales Revenue Split, By Geography Segment (%), FY2020
13.4 Alnylam Pharmaceuticals Inc.
Table 119: Alnylam Pharmaceuticals Inc. Sales Revenues, 2016-2020 (USD Million)
Table 120: Alnylam Pharmaceuticals Inc. sales Revenues, By Business Segment (%), FY2020
Table 121: Alnylam Pharmaceuticals Inc. sales Revenue, By Geographical Segment (%), FY2020
13.5 Pfizer
Table 122: Pfizer Annual Sales Revenue (USD Million), 2016-2020
Table 123: Pfizer Annual Net Income/Loss (USD Million), 2016-2020
Table 124: Pfizer sales Revenue, By Geographical Segment (%), FY2020
13.6 BlueBird Inc.
Table 125: BlueBird Bio Inc. Sales Revenues, 2015-2019 (USD Million)
13.7 Sarepta Therapeutics
Table 126: Sarepta Therapeutics Sales Revenues, 2015-2019 (USD Million)
13.8 Voyager Therapeutics
Table 127: Voyager Therapeutics Sales Revenues, 2015-2019 (USD Million)
13.9 Orchard Therapeutics Plc
Table 128: Orchard Therapeutics PLC Sales Revenues, 2018-2020 (USD Million)
13.10 AnGes Inc.
Table 129: AnGes Inc. Sales Revenues, 2015-2019 (USD Million)